We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+18.21%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$603M
AUM Growth
+$208M
(+53%)
Cap. Flow
+$141M
Cap. Flow
% of AUM
23.44%
Top 10 Holdings %
Top 10 Hldgs %
55.19%
Holding
77
New
23
Increased
8
Reduced
17
Closed
9
Top Buys
| 1 |
Cigna
CI
|
+$48.3M |
| 2 |
Zimmer Biomet
ZBH
|
+$36.6M |
| 3 |
Organon & Co
OGN
|
+$27M |
| 4 |
Icon
ICLR
|
+$22.7M |
| 5 |
WAY
Waystar Holding Corp
WAY
|
+$21.9M |
Top Sells
| 1 |
Celcuity
CELC
|
+$25.4M |
| 2 |
Disc Medicine
IRON
|
+$19.2M |
| 3 |
Alkermes
ALKS
|
+$17.4M |
| 4 |
Merck
MRK
|
+$14.9M |
| 5 |
Henry Schein
HSIC
|
+$14.5M |
Sector Composition
| 1 | Healthcare | 88.65% |
| 2 | Industrials | 7.16% |
| 3 | Consumer Staples | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Celcuity
CELC
$5.42B
| $47.6M | 7.89% |
477,067
-309,459
| -39% | -$25.4M |
|
|
2
Cigna
CI
$80.2B
| $47.4M | 7.86% |
+172,203
| New | +$48.3M |
|
3
Sanofi
SNY
$103B
| $47.1M | 7.81% |
971,686
+408,983
| +73% | +$20.3M |
|
4
Maximus
MMS
$3.03B
| $43.2M | 7.16% |
500,304
-57,311
| -10% | -$4.9M |
|
|
5
Zimmer Biomet
ZBH
$17.6B
| $34.7M | 5.75% |
+385,642
| New | +$36.6M |
|
6
Kenvue
KVUE
$36B
| $25.3M | 4.19% |
1,465,442
+621,442
| +74% | +$10.2M |
|
|
7
Organon & Co
OGN
$3.55B
| $24.5M | 4.07% |
+3,421,765
| New | +$27M |
|
|
8
Icon
ICLR
$13B
| $23.2M | 3.84% |
+127,202
| New | +$22.7M |
|
|
WAY
9
Waystar Holding Corp
WAY
$4.26B
| $20.1M | 3.33% |
+613,725
| New | +$21.9M |
|
10
LivaNova
LIVN
$4.35B
| $19.8M | 3.29% |
+322,382
| New | +$18.4M |
|
11
Dianthus Therapeutics
DNTH
$5.54B
| $19.6M | 3.24% |
474,503
-103,247
| -18% | -$4M |
|
12
Biohaven
BHVN
$2.25B
| $14.1M | 2.33% |
+1,244,764
| New | +$15.4M |
|
13
Structure Therapeutics
GPCR
$3.6B
| $14M | 2.32% |
+201,500
| New | +$8.23M |
|
14
BioMarin Pharmaceuticals
BMRN
$11.3B
| $13.8M | 2.29% |
232,688
+7,574
| +3% | +$412K |
|
15
Tyra Biosciences
TYRA
$1.96B
| $13.8M | 2.29% |
526,002
+11,055
| +2% | +$203K |
|
16
BrightSpring Health Services
BTSG
$13.7B
| $11.5M | 1.91% |
+308,010
| New | +$10.3M |
|
17
Centene
CNC
$33.9B
| $11.3M | 1.87% |
274,350
-113,250
| -29% | -$4.24M |
|
18
Charles River Laboratories
CRL
$11.1B
| $11M | 1.82% |
+54,985
| New | +$9.97M |
|
19
Teleflex
TFX
$5.76B
| $10.6M | 1.76% |
86,876
+46,819
| +117% | +$5.67M |
|
|
AVR
20
Anteris Technologies
AVR
$871M
| $9.35M | 1.55% |
1,874,641
+102,040
| +6% | +$468K |
|
21
Protara Therapeutics
TARA
$230M
| $9.14M | 1.52% |
+1,715,394
| New | +$9.54M |
|
22
Cross Country Healthcare
CCRN
$427M
| $8.66M | 1.44% |
+1,068,821
| New | +$11.7M |
|
23
Haemonetics
HAE
$3.38B
| $7.42M | 1.23% |
92,631
-105,404
| -53% | -$7.08M |
|
24
ANI Pharmaceuticals
ANIP
$1.83B
| $6.89M | 1.14% |
87,272
+31,549
| +57% | +$2.73M |
|
25
Aquestive Therapeutics
AQST
$507M
| $6.42M | 1.06% |
993,095
-505,000
| -34% | -$3.15M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA